Patent · US Active

Fumarate salt of (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol

US8546428B2 · kind B2 · utility

1Cited by

2References

12Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Jean Francois Alexandre Lucas Hegyi · Diest, BE
Wim Albert Alex Aelterman · Gierle, BE
Yolande Lydia Lang · Vosselaar, BE
Sigrid Carl Maria Stokbroekx · Beerse, BE
Carina Leys · Stabroek, BE
Peter Jozef Maria Van Remoortere · Princeton, US
Anne Faure · Vosselaar, BE

Key dates

Filing date	Dec 3, 2007
Grant date	Oct 1, 2013
Priority date	—
Expiry date	Mar 19, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the fumarate salt of (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol, pharmaceutical compositions comprising as active ingredient said salt and to processes for their preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.